ClariTrial | Search Clinical Trials

VeriSee AI-assisted screening tools for diabetic retinopathy and age-related macular degenerationStandard fundus photography with physician interpretation

National Taiwan University Hospital4,300 participants1 site · TaiwanCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

An Efficacy and Safety Study of DFL24498 in the Treatment of AKC

Phase 3Atopic Keratoconjunctivitis

DFL24498Vehicledexamethasone sodium phosphate (DSP) ophthalmic solution

Dompé Farmaceutici S.p.A153 participants19 sites · United States, Italy, SpainCompletes Mar 2027

Compare CT.gov Full analysis →

1–15 of 158

Explore/eye disease ophthalmology retina

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

158 results for “eye disease ophthalmology retina” · Recruiting

Page 1 of 11

Recruiting

Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration

N/AAge-related Macular Degeneration (AMD)

No intervention.

iHealthScreen Inc1,076 participants1 site · United StatesCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice

N/AVision Impairment and BlindnessGlaucomaAge-Related Macular Degeneration

focus on vision impairment in older patients in general practice

University of Copenhagen460 participants2 sites · DenmarkCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Morphological Characteristics of the Maxillomandibular Region in a 3D Representation and the Refractive Status of the Eye

N/ARefractive Errors

No intervention; Observational study

University of Zagreb120 participants1 site · CroatiaCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Azathioprine in MOGAD

Phase 3Central Nervous System InflammationMOG-IgG Associated Disease

AzathioprinePlacebo

Hospices Civils de Lyon126 participants17 sites · FranceCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Determination of Physical Parameters Relevant to Ophthalmic Lasers

N/AHealthy Volunteers

Sheba Medical Center20 participants1 site · IsraelCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

No Endotamponade for Macular Hole Repair: the NEMAR Study

N/AMacular HoleMacular Hole Surgery

Conventional surgeryILM flap with no gas tamponade

Chinese University of Hong Kong180 participants3 sites · Hong Kong, Poland, TaiwanCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene

Phase 1Retinitis Pigmentosa

VG901

VeonGen Therapeutics GmbH6 participants1 site · GermanyCompletes Apr 2026

Compare CT.gov Full analysis →

Recruiting

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

Phase 3Neovascular Age-related Macular DegenerationnAMD

ABP 938 8 mgAflibercept (US) 8 mg

Amgen304 participants81 sites · United States, Czechia, HungaryCompletes Jul 2027

Compare CT.gov Full analysis →

Recruiting

Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy

N/ADiabetes (DM)Retinopathy, DiabeticDiabetic Retinopathy (DR)

Sara A Belal70 participants1 site · EgyptCompletes Aug 2026

Compare CT.gov Full analysis →

Recruiting

Comparison of Anatomical and Functional Outcomes of Laser Photocoagulation and Cryopexy in Patients with Rhegmatogenous Retinal Detachment Treated with Pneumatic Retinopexy

N/ARhegmatogenous Retinal Detachment

Pneumatic retinopexy with transscleral cryopexyPneumatic retinopexy with laser photocoagulation

Clinical Hospital Center, Split40 participants1 site · CroatiaCompletes Nov 2025

Compare CT.gov Full analysis →

Recruiting

Retinoblastoma Patient Clinical Database and Tissue Repository

N/ARetinoblastomaRetinoblastoma BilateralRetinoblastoma Unilateral

Children's Hospital Los Angeles800 participants9 sites · United States, CanadaCompletes Dec 2028

Compare CT.gov Full analysis →

Recruiting

N/AAge-Related Macular Degeneration (AMD)

treatment with Aflibercept 8mg (Eylea)

Insel Gruppe AG, University Hospital Bern50 participants1 site · SwitzerlandCompletes Mar 2026

Compare CT.gov Full analysis →

Recruiting

Changes in Eye Pressure in Glaucoma Patients Treated with Istent Inject W, Monitored by a Contact Lens Sensor

N/AGlaucoma Eye

Monitoring with contact lens sensorMonitoring with contact lens sensorMonitoring with contact lens sensor

Fundacio Privada Mon Clinic Barcelona53 participants2 sites · SpainCompletes Oct 2025

Compare CT.gov Full analysis →

Recruiting

Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics

N/AAge-Related Macular Degeneration (AMD)Diabetic Retinopathy (DR)

VeriSee AI-assisted screening tools for diabetic retinopathy and age-related macular degenerationStandard fundus photography with physician interpretation

National Taiwan University Hospital4,300 participants1 site · TaiwanCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

An Efficacy and Safety Study of DFL24498 in the Treatment of AKC

Phase 3Atopic Keratoconjunctivitis

DFL24498Vehicledexamethasone sodium phosphate (DSP) ophthalmic solution

Dompé Farmaceutici S.p.A153 participants19 sites · United States, Italy, SpainCompletes Mar 2027

Compare CT.gov Full analysis →

1–15 of 158